Last deal

$10.7M

Amount

Grant

Stage

14.06.2024

Date

9

all rounds

$12.8M

Total amount

General

About Company
MIMOSA Diagnostics is a connected care platform that enables remote monitoring and assessment of tissue health.

Industry

Sector :

Subsector :

Keywords :

Also Known As

MIMOSA

founded date

15.08.2016

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

MIMOSA Diagnostics is an m-health tech startup that offers a handheld device and smartphone app for visualizing skin health. Their AI diagnostic data warehouse integrates metadata insights with patient EMR/EHR systems, initially focusing on the Diabetes sector. MIMOSA's proprietary algorithms risk profile the skin in various clinical settings, providing accurate and inclusive results regardless of skin color. Their technology aims to make healthcare more personalized, efficient, and equitable, empowering clinicians to implement early interventions and prevent the need for further treatments. MIMOSA's products also enable patients in remote areas and racialized communities worldwide to access critical healthcare.
Contacts